Antithrombin-III — Drug Target
All drugs that target Antithrombin-III — marketed and clinical-stage. Includes 4 drug classes acting on this target.
Drug classes
Low Molecular Weight Heparin · Anti-coagulant · Anticoagulant · Low molecular weight heparin
Marketed (4)
- Enoxaparin · Dana-Farber Cancer Institute · Cardiovascular
- Lovenox (Preservative Free) · Sanofi · Low Molecular Weight Heparin · Cardiovascular
Lovenox works by enhancing the activity of antithrombin-III to inhibit blood clotting. - Lovenox · University of Monastir · Cardiovascular
- Heparin Sodium In Plastic Container · Merck & Co. · Anti-coagulant · Cardiovascular
Heparin works by binding to Antithrombin-III, a protein that inhibits the formation of blood clots.
Phase 3 pipeline (2)
- sham mPENTOCLO · Sunnybrook Health Sciences Centre · Anticoagulant · Cardiovascular
Pentosan polysulfate sodium is an anticoagulant that works by inhibiting the coagulation cascade. - UFH · VarmX B.V. · Low molecular weight heparin · Cardiovascular
UFH acts as an anticoagulant by inhibiting the coagulation cascade, specifically by inactivating Factor Xa and thrombin.